The deal to buy informatics firm Geospiza is complementary to PerkinElmer's launch of its next-generation sequencing service in January and fits in with a strategy to move toward a business model with greater emphasis on recurring revenues.
Full-text access for registered users only.
Existing users login here.
New to GenomeWeb? Register here quickly for free access.